Hemangiosarcoma - 13 Studies Found
| Active, not recruiting |
: Bevacizumab in Treating Patients With Angiosarcoma : Sarcoma : 2006-02-06 : Biological: Bevacizumab Bevacizumab 15 mg/kg IV infusion given on day 1 every 21 days = (1 cycle). |
| Active, not recruiting |
: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas : Soft Tissue Sarcoma : 2010-06-08 : Drug: Axitinib Patients will take axitinib tablets 5 mg by mouth twice daily continuously. There may be |
| Completed |
: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes :
|